The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Iversen Leslie L since 2006.
The trader's CIK number is 1291623.
At the time of the last reporting, Iversen Leslie L was the Director of Acadia Pharmaceuticals Inc. (stock ticker symbol ACAD).
Also see all insider trading activities at Acadia Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | ACAD | 0 | $0 | 33,697 | $1,129,995 | 33,697 | $58,969 |
| 2015 | ACAD | 0 | $0 | 30,000 | $1,080,330 | 61,127 | $528,533 |
| 2014 | ACAD | 0 | $0 | 60,000 | $1,501,740 | 60,000 | $112,380 |
| 2013 | ACAD | 0 | $0 | 60,000 | $1,375,440 | 64,500 | $174,000 |
| 2009 | ACAD | 3,000 | $4,950 | 0 | $0 | 0 | $0 |
| 2008 | ACAD | 0 | $0 | 0 | $0 | 3,000 | $1,200 |
| 2006 | ACAD | 0 | $0 | 0 | $0 | 3,000 | $1,500 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-04-18 | ACAD | Option Ex | 33,697 | 1.75 | 58,969 |
| 2016-04-18 | ACAD | Sale | 33,697 | 33.53 | 1,129,995 |
| 2015-11-11 | ACAD | Option Ex | 30,000 | 7.22 | 216,510 |
| 2015-11-11 | ACAD | Sale | 30,000 | 36.01 | 1,080,330 |
| 2015-08-19 | ACAD | Option Ex | 8,500 | 11.00 | 93,500 |
| 2015-08-19 | ACAD | Option Ex | 8,500 | 11.00 | 93,500 |
| 2015-06-01 | ACAD | Option Ex | 14,127 | 8.85 | 125,023 |
| 2014-01-02 | ACAD | Option Ex | 60,000 | 1.87 | 112,380 |
| 2014-01-02 | ACAD | Sale | 60,000 | 25.03 | 1,501,740 |
| 2013-09-12 | ACAD | Sale | 60,000 | 22.92 | 1,375,440 |
| 2013-09-12 | ACAD | Option Ex | 60,000 | 2.90 | 174,000 |
| 2013-02-21 | ACAD | Option Ex | 4,500 | .00 | 0 |
| 2009-05-18 | ACAD | Buy | 3,000 | 1.65 | 4,950 |
| 2008-08-21 | ACAD | Option Ex | 2,000 | .00 | 0 |
| 2008-02-11 | ACAD | Option Ex | 1,000 | 1.20 | 1,200 |
| 2006-12-11 | ACAD | Option Ex | 3,000 | .50 | 1,500 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Iversen Leslie L (Director of Acadia Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.